- Home
- AUPH vs SDHC Comparison
AUPH vs SDHC Comparison
Compare AUPH & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- SDHC
- Stock Information
- Founded
- AUPH 1993
- SDHC 2008
- Country
- AUPH Canada
- SDHC United States
- Employees
- AUPH N/A
- SDHC N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- SDHC
- Sector
- AUPH Health Care
- SDHC
- Exchange
- AUPH Nasdaq
- SDHC Nasdaq
- Market Cap
- AUPH 1.1B
- SDHC 933.4M
- IPO Year
- AUPH 1999
- SDHC 2024
- Fundamental
- Price
- AUPH $8.19
- SDHC $19.28
- Analyst Decision
- AUPH Strong Buy
- SDHC Hold
- Analyst Count
- AUPH 2
- SDHC 4
- Target Price
- AUPH $11.50
- SDHC $23.63
- AVG Volume (30 Days)
- AUPH 1.4M
- SDHC 73.9K
- Earning Date
- AUPH 07-31-2025
- SDHC 05-14-2025
- Dividend Yield
- AUPH N/A
- SDHC N/A
- EPS Growth
- AUPH N/A
- SDHC N/A
- EPS
- AUPH 0.27
- SDHC 0.24
- Revenue
- AUPH $247,295,000.00
- SDHC $1,010,976,000.00
- Revenue This Year
- AUPH $12.15
- SDHC $4.36
- Revenue Next Year
- AUPH $18.31
- SDHC $10.90
- P/E Ratio
- AUPH $30.78
- SDHC $80.15
- Revenue Growth
- AUPH 29.20
- SDHC 28.67
- 52 Week Low
- AUPH $5.15
- SDHC $16.28
- 52 Week High
- AUPH $10.67
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- AUPH 54.75
- SDHC 52.84
- Support Level
- AUPH $7.91
- SDHC $17.50
- Resistance Level
- AUPH $8.07
- SDHC $19.50
- Average True Range (ATR)
- AUPH 0.24
- SDHC 1.12
- MACD
- AUPH -0.00
- SDHC 0.20
- Stochastic Oscillator
- AUPH 51.85
- SDHC 77.74
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.